Lab Results
What Is an Optimal LDL Level?: A Functional-Medicine Interpretation Guide
Your LDL cholesterol result came back 'normal' — but are you actually protected from cardiovascular risk? Functional medicine draws a sharper line than standard reference ranges, and emerging research suggests that LDL particle number and particle size matter as much as the raw cholesterol number. Understanding what optimal truly looks like can change your entire approach to heart health.
What Is an Optimal LDL Level? A Functional-Medicine Interpretation Guide
For decades, the conversation around cholesterol was simple: keep your LDL low, keep your HDL high, and you're probably fine. That picture has grown considerably more nuanced. Conventional labs flag LDL as 'high' only when it crosses 130 mg/dL or above, yet cardiologists and functional-medicine practitioners have watched patients suffer cardiovascular events with LDL values squarely in the 'normal' range. The missing variable is almost always particle quality — not just quantity.
This guide walks through what an optimal LDL level actually looks like from a functional-medicine lens, why LDL particle number is increasingly considered the superior metric, what clinical research says about risk thresholds, and how to use this information to make smarter decisions about your cardiovascular health.
---
What Is an Optimal LDL Cholesterol Level?
The standard lipid panel measures LDL-C: the estimated concentration of cholesterol carried inside LDL particles. Most labs flag anything below 100 mg/dL as 'optimal' for average-risk adults, but the American Heart Association and the 2018 ACC/AHA Cholesterol Guidelines stratify targets much more granularly based on individual cardiovascular risk (Grundy et al., Circulation 2019; PMID: 30586774).
From a functional-medicine standpoint, the conversation typically looks like this:
| LDL-C Range (mg/dL) | Conventional Label | Functional-Medicine Interpretation |
|---|---|---|
| < 70 | Optimal (very high-risk patients) | Target for anyone with prior CVD or metabolic syndrome |
| 70–99 | Near optimal | Acceptable for low-risk adults; monitor particle number |
| 100–129 | Borderline | Warrants deeper investigation (NMR, ApoB) |
| 130–159 | Borderline high | Lifestyle intervention + full metabolic panel |
| ≥ 160 | High | Clinical attention required |
The critical limitation of LDL-C alone is what researchers call the 'LDL discordance problem.' A significant subset of people have normal LDL-C but elevated LDL particle number (LDL-P) or apolipoprotein B (ApoB), and these individuals carry substantially higher cardiovascular risk than their standard panel suggests (Cromwell et al., Journal of Clinical Lipidology 2007; PMID: 21291838).
For functional-medicine practitioners, LDL-C targets often sit between 70–100 mg/dL for otherwise healthy adults, with a strong emphasis on keeping LDL particle number and ApoB within optimal ranges regardless of the cholesterol number.
---
What Is an Optimal LDL Particle Number Level?
LDL particle number (LDL-P), measured via nuclear magnetic resonance (NMR) spectroscopy on a test like the NMR LipoProfile or Boston Heart Diagnostics panel, counts the actual number of LDL particles in the blood rather than just their cholesterol cargo.
Why does this matter? Imagine two people both with an LDL-C of 100 mg/dL. Person A has 800 large, buoyant LDL particles carrying that cholesterol. Person B has 1,800 small, dense LDL particles carrying the same load. Person B has dramatically more atherogenic potential — more particles means more opportunities for oxidation, endothelial penetration, and plaque formation. Their standard lipid panel looks identical; their particle panel looks completely different.
This was demonstrated clearly in the MESA (Multi-Ethnic Study of Atherosclerosis) cohort, where LDL-P was a stronger predictor of cardiovascular events than LDL-C across all ethnic groups studied (Mora et al., Journal of the American College of Cardiology 2009; PMID: 19555847).
Functional-medicine optimal ranges for LDL-P:
| Metric | Conventional Reference | Functional-Medicine Optimal |
|---|---|---|
| LDL-P (total) | < 1,000 nmol/L (low risk) | < 700 nmol/L |
| Small LDL-P | < 527 nmol/L | < 200 nmol/L |
| ApoB (proxy for LDL-P) | < 100 mg/dL | < 80 mg/dL |
| LDL size | > 20.5 nm (Pattern A) | Pattern A preferred |
ApoB is worth highlighting here because it's far more accessible than NMR testing. Each LDL particle carries exactly one ApoB protein, so ApoB concentration is essentially a direct surrogate for LDL-P. The 2021 European Atherosclerosis Society consensus paper confirmed that ApoB is the superior lipid metric for cardiovascular risk and recommended it be used preferentially over calculated LDL-C (Handelsman et al., Atherosclerosis 2021; PMID: 34420770).
If your standard LDL-C appears normal but your ApoB exceeds 90 mg/dL or your LDL-P exceeds 1,000 nmol/L, functional practitioners will typically treat those elevated markers as the more clinically significant findings.
---
Why Small, Dense LDL Particles Drive Cardiovascular Risk
Not all LDL is created equal — and this is where the real complexity lies. Small, dense LDL (sdLDL) particles are:
- More easily oxidized by reactive oxygen species
- Retained longer in arterial walls due to their smaller size
- Less efficiently cleared by hepatic LDL receptors
- More associated with insulin resistance, high triglycerides, and low HDL (a pattern called 'atherogenic dyslipidemia')
A 2014 meta-analysis in the European Heart Journal found that elevated sdLDL concentration was associated with approximately a 3-fold increased risk of coronary heart disease, independent of total LDL-C levels (Hoogeveen et al., European Heart Journal 2014; PMID: 24366919).
This is exactly why fasting triglycerides matter alongside your LDL panel. Triglycerides > 150 mg/dL in the context of low HDL (< 40 mg/dL men, < 50 mg/dL women) is a strong signal that small, dense LDL predominates — even when LDL-C looks reassuring.
Lifestyle factors that shift LDL particle size favorably include:
- Replacing refined carbohydrates with whole-food fats and fiber
- Regular aerobic exercise (150+ minutes weekly at moderate intensity)
- Omega-3 fatty acid supplementation at clinical doses
- Optimizing insulin sensitivity (reducing fasting insulin and HbA1c)
- Addressing thyroid function (see below — hypothyroidism significantly worsens lipid profiles)
---
What Is an Optimal Free T4 Level? (And Why It Appears on Your Lipid Workup)
You might wonder what thyroid markers are doing in an article about LDL. The connection is direct and clinically important: thyroid hormones regulate the expression of LDL receptors on liver cells. When free T4 (FT4) and triiodothyronine (T3) are suboptimal — even within conventional 'normal' ranges — LDL clearance slows, and LDL-C and LDL-P rise as a consequence.
Subclinical hypothyroidism, defined as elevated TSH with normal FT4, is associated with measurably higher LDL-C and ApoB levels even before the patient is symptomatic (Pearce et al., NEJM 2012; PMID: 22853014). This is why a thorough cardiovascular workup in functional medicine almost always includes a full thyroid panel — TSH, free T4, free T3, and thyroid antibodies.
Functional-medicine optimal ranges for free T4:
| Metric | Lab Reference Range | Functional-Medicine Optimal |
|---|---|---|
| Free T4 | 0.8–1.8 ng/dL | 1.1–1.7 ng/dL (upper half of range) |
| Free T3 | 2.3–4.2 pg/mL | 3.2–4.0 pg/mL |
| TSH | 0.45–4.5 mIU/L | 1.0–2.0 mIU/L |
If thyroid function is silently depressed, optimizing it — through medication when indicated, or through thyroid-supportive nutrition — can produce a meaningful and measurable drop in LDL-C without any change in diet. This reinforces why addressing root causes, not just isolated biomarkers, is central to functional medicine.
---
What Is an Optimal Thyroid Antibodies Level?
Thyroid antibody testing — specifically anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TgAb) antibodies — is relevant to LDL optimization because autoimmune thyroid disease (Hashimoto's thyroiditis) is the most common cause of subclinical and overt hypothyroidism in developed countries. Elevated thyroid antibodies precede frank hypothyroidism by years and can silently impair lipid clearance long before TSH becomes abnormal.
Functional-medicine interpretation of thyroid antibodies:
| Antibody | Lab Reference (negative) | Functional-Medicine Concern Threshold |
|---|---|---|
| Anti-TPO | < 35 IU/mL | Any value > 20 IU/mL warrants monitoring |
| Anti-TgAb | < 20 IU/mL | Trending upward signals early autoimmune activity |
A positive anti-TPO antibody finding — even with 'normal' TSH — is sufficient reason in functional medicine to investigate LDL particle quality alongside thyroid optimization strategies. Addressing systemic inflammation and immune dysregulation often improves both thyroid function and lipid profiles simultaneously.
For more on how thyroid health connects to other metabolic markers, see our guide to understanding your full thyroid panel and what the numbers mean.
---
Nutrients That Support Optimal LDL and Lipid Particle Quality
Beyond lifestyle, several clinically-researched nutrients have demonstrated measurable effects on LDL-C, LDL-P, and cardiovascular risk markers:
Omega-3 Fatty Acids (EPA/DHA): High-dose omega-3s primarily reduce triglycerides (by 20–50% at 3–4g/day), which indirectly improves LDL particle size by shifting composition away from sdLDL. The REDUCE-IT trial demonstrated a 25% reduction in cardiovascular events with 4g/day icosapentaenoic acid in statin-treated patients with elevated triglycerides (Bhatt et al., NEJM 2019; PMID: 30415628). Even at standard supplementation doses of 1–2g EPA+DHA, consistent improvements in triglycerides and LDL particle size are well-documented.
Berberine: This plant alkaloid activates AMP-kinase and upregulates hepatic LDL receptors via a mechanism distinct from statins. A meta-analysis of 27 randomized controlled trials found berberine reduced LDL-C by an average of 0.65 mmol/L and triglycerides by 0.50 mmol/L (Dong et al., Planta Medica 2013; PMID: 23512497).
CoQ10 (Ubiquinol): While CoQ10 doesn't directly lower LDL-C, it reduces LDL oxidation — the critical step that makes LDL particles atherogenic. Oxidized LDL is preferentially taken up by macrophages to form foam cells and atherosclerotic plaques. CoQ10 at 200mg/day has been shown to significantly reduce oxidized LDL in clinical populations.
Plant Sterols/Stanols: At 2g/day, plant sterols competitively inhibit intestinal cholesterol absorption and reliably reduce LDL-C by 8–10% — a well-established mechanism recognized by the FDA as sufficient to carry a qualified health claim.
---
What This Means for Your Formula
At Ones, the approach to cardiovascular biomarkers goes beyond a single cholesterol number. When blood work and health history reveal elevated LDL-P, ApoB, or small dense LDL alongside metabolic dysfunction, the AI health practitioner looks at the full picture — including thyroid markers, fasting insulin, triglycerides, and inflammatory indicators like hsCRP — before building a personalized capsule formula.
For lipid optimization specifically, formulas may incorporate:
- Omega-3 (EPA/DHA) at clinically effective doses targeting triglyceride reduction and LDL particle size improvement — consistent with the dosing framework used in major trials. This is especially prioritized when the LDL-P/LDL-C discordance pattern is present alongside elevated triglycerides.
- CoQ10 (Ubiquinol at 200mg) — included not only for mitochondrial energy support but specifically for its role in reducing LDL oxidation, a mechanism that matters most when LDL-P is elevated and particle atherogenicity is the concern.
- Heart Support (proprietary System Blend) — Ones' Heart Support blend combines targeted compounds designed to address multiple cardiovascular pathways simultaneously, calibrated to the individual's biomarker profile rather than a one-size-fits-all cardiovascular formula.
If thyroid markers are suboptimal alongside the lipid findings, the formula may also address thyroid-related pathways through the Thyroid Support blend — recognizing that normalizing thyroid function can produce meaningful downstream improvements in LDL clearance.
Learn more about how Omega-3 dosing affects cardiovascular biomarkers and why particle quality matters more than the number on your standard lipid panel.
For a broader look at how LDL connects to other metabolic markers, our overview of interpreting your full cholesterol panel beyond LDL-C covers HDL, triglycerides, and non-HDL cholesterol in detail.
---
Key Takeaways
- Standard LDL-C is not the full story. Functional medicine targets LDL-C below 100 mg/dL for average-risk adults, but LDL particle number (LDL-P) and ApoB are considered superior predictors of cardiovascular risk.
- LDL-P below 700 nmol/L and ApoB below 80 mg/dL are functional-medicine optimal thresholds — both meaningfully tighter than conventional lab reference ranges.
- Small, dense LDL particles are the primary atherogenic driver, not total cholesterol cargo. High triglycerides and low HDL signal sdLDL predominance even when LDL-C appears normal.
- Thyroid function directly regulates LDL clearance. Suboptimal free T4 and elevated thyroid antibodies can cause LDL-C and LDL-P to rise silently — making a full thyroid panel essential in any cardiovascular workup.
- Omega-3 EPA/DHA at clinical doses, CoQ10 (Ubiquinol 200mg), and berberine have the strongest evidence for improving LDL particle quality, reducing triglycerides, and protecting against LDL oxidation.
- Consult a healthcare provider before making changes to medications or treatment plans based on these ranges — functional targets are guides for optimization, not diagnostic criteria.